Aortic valve replacement: is the stentless xenograft an alternative to the homograft? midterm results Christoph Gross, MD, Wolfgang Harringer, MD, Helmut Beran, PhD, Rudolf Mair, MD, Kurt Sihorsch, MD, Robert Hofmann, MD, Peter Brücke, MD The Annals of Thoracic Surgery Volume 68, Issue 3, Pages 919-924 (September 1999) DOI: 10.1016/S0003-4975(99)00535-4
Fig 1 Actuarial estimate. Freedom from valve-related death. HX = patient with homograft valves; SX = patient with xenograft valves. Patients at risk are reported in parentheses. The Annals of Thoracic Surgery 1999 68, 919-924DOI: (10.1016/S0003-4975(99)00535-4)
Fig 2 Actuarial estimate. Patient survival. HX = patient with homograft valves; SX = patient with xenograft valves. Patients at risk are reported in parentheses. The Annals of Thoracic Surgery 1999 68, 919-924DOI: (10.1016/S0003-4975(99)00535-4)
Fig 3 Actuarial estimate. Freedom from endocarditis. HX = patient with homograft valves; SX = patients with stentless xenograft valves. Patients at risk are reported in parentheses. The Annals of Thoracic Surgery 1999 68, 919-924DOI: (10.1016/S0003-4975(99)00535-4)